Association Between Clinical Manifestations and Prognosis in Patients with COVID-19Tao Yu, Xuwen Xu, Sichun Yin et al.|Clinical Therapeutics|2020Cited by 84
Risk factors associated with liver steatosis and fibrosis in chronic hepatitis B patient with component of metabolic syndromeShaohang Cai, Jie Peng, Ying Liu et al.|United European Gastroenterology Journal|2018Cited by 56
Comparison of entecavir monotherapy and de novo lamivudine and adefovir combination therapy in HBeAg-positive chronic hepatitis B with high viral load: 48-week resultShaohang Cai, Jie Peng, Tao Yu et al.|Clinical and Experimental Medicine|2015Cited by 48
Serum hepatitis B core antibody levels predict HBeAg seroconversion in chronic hepatitis B patients with high viral load treated with nucleos(t)ide analogsShaohang Cai, Jie Peng, Zhandong Li et al.|Infection and Drug Resistance|2018Cited by 43
Effectiveness of entecavir or telbivudine therapy in patients with chronic hepatitis B virus infection pre-treated with interferon compared with de novo therapy with entecavir and telbivudineShaohang Cai, Jie Peng, Jiawei Cao et al.|Medicine|2017Cited by 34